Table 1 Ex vivo pattern of expression of individual markers on CD13high CD105+ CD45− cells from normal/reactive bone marrow samples
Code | Antigen | Expression pattern | % of positive cellsa | Amount of protein expressed/cellb |
|---|---|---|---|---|
(% of positive cases; positive cases/total cases) | ||||
CD10 | Neprilysin | −/+ | 89 % | 6916 |
(100 %; 18/18) | (62–97 %) | (1883–22,177) | ||
CD11b | Integrin alpha-M | – | NA | NA |
(0 %; 0/9) | ||||
CD13 | Aminopeptidase N | ++/+++ | 100 % | 122,414 |
(100 %; 60/60) | (100–100 %) | (45,582–260,438) | ||
CD14 | Myeloid Cell-Specific Leucine-Rich Glycoprotein | – | NA | NA |
(0 %; 0/47) | ||||
CD19 | B-Lymphocyte Surface Antigen B4 | – | NA | NA |
(0 %; 0/37) | ||||
CD34 | Hematopoietic Progenitor Cell Antigen-1 | – | NA | NA |
(0 %; 0/60) | ||||
CD45 | Leukocyte common antigen | – | NA | NA |
(0 %; 0/60) | ||||
CD73 | Ecto-5′-nucleotidase | +/++ | 100 % | 7816 |
(100 %; 58/58) | (100–100 %) | (3268–23,090) | ||
CD90 | Thy-1 | +/+++ | 100 % | 21,875 |
(100 %; 55/55) | (100–100 %) | (1870–260,738) | ||
CD105 | Endoglin | + | 100 % | 2463 |
(100 %; 60/60) | (100–100 %) | (700–4620) | ||
CD117 | Kit | – | NA | NA |
(0 %; 0/54) | ||||
CD146 | Melanoma cell adhesion molecule | +Low | 100 % | 547 |
(100 %; 55/55) | (100–100 %) | (267–3054) | ||
NA | HLA-DR | −/+ | 91 % | 3296 |
(100 %; 34/34) | (50–100 %) | (390–15,823) |